APA (7th ed.) Citation

Green, D. J., Burnham, J. M., Schuette, P., Liu, X. I., Maas, B. M., Yao, L., . . . Burckart, G. J. (2018). Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA. Journal of clinical pharmacology, 58(7), 885. https://doi.org/10.1002/jcph.1109

Chicago Style (17th ed.) Citation

Green, Dionna J., et al. "Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA." Journal of Clinical Pharmacology 58, no. 7 (2018): 885. https://doi.org/10.1002/jcph.1109.

MLA (9th ed.) Citation

Green, Dionna J., et al. "Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDA." Journal of Clinical Pharmacology, vol. 58, no. 7, 2018, p. 885, https://doi.org/10.1002/jcph.1109.